Cancer Molecular Pathology and Therapeutics MSc, PGCert

1 year full-time

This is for you if... you want to study the molecular pathology, biology and therapeutics of cancer at an advanced level and develop a dynamic career in biological research or continue with further postgraduate study.

Cancer Molecular Pathology and Therapeutics MSc, PGCert, 1 year full-time

This is for you if... you want to study the molecular pathology, biology and therapeutics of cancer at an advanced level and develop a dynamic career in biological research or continue with further postgraduate study.

Course information

UK fee £9,900

International fee £21,850

Contact
Professor Karen Brown, Dr David Guttery, Professor Donald Jones
Leicester Cancer Research Centre
Robert Kilpatrick Building
Leicester Royal Infirmary
Leicester LE2 7LX
+44 (0)116 223 1841
cmpt@le.ac.uk

School of Biological Sciences website

Course description

Course description

Join a world-leading cancer research centre by studying MSc Cancer Molecular Pathology and Therapeutics at one of the top research universities in the UK. 

The University of Leicester has a truly global reputation for its research into a range of clinical disciplines including molecular cancer therapeutics, heart disease, diabetes and genetics. The University is also home to the prestigious Leicester Cancer Research Centre, which conducts real-life trials and lifesaving research into this terrible disease. 

By studying Cancer Molecular Pathology and Therapeutics at postgraduate level (MSc or PGCert are available), you will be taught by internationally-renowned researchers and clinicians at the forefront of cancer research and treatment, being equipped with the knowledge, expertise and experience to make a real positive contribution towards the future research and treatment of cancer. 

You will study the mechanistic nature of cancer biology and apply that knowledge to better understanding and developing the future diagnosis, prognosis therapy and prevention of cancer. Building on a solid foundation of learned basic cancer cell biology, you will consider and experience the design of treatment modalities and prevention strategies, including the mechanisms of action of anti-cancer drugs and radiation treatment, therapy resistance and biomarker discovery.

This Cancer Therapeutics Masters degree course comprises three months of intensive lectures, tutorials and taught lab work, followed by a further month of advanced topic lectures delivered by scientists at the cutting-edge of translational research, focusing on therapeutics and prevention. 

A key component of the course is then the five to six month research project, which will give you the opportunity to study and research one of the department’s key research areas in much greater depth. As well as developing your understanding of the processes and techniques used in cancer research, you will learn how to critically analyse research data and research papers and how to communicate complex scientific concepts and processes, as well as contributing to the world-leading research that each laboratory undertakes.

Entry requirements

Entry requirements

2:2 degree (or equivalent) in a relevant bioscience subject such as biology, molecular biology, biochemistry, biotechnology, pharmacology etc.

We also welcome applicants with significant relevant industrial or professional experience, and medically qualified applicants with a strong background in molecular biology and/or cell biology.

English Language Requirements

IELTS 6.5 or equivalent. If your first language is not English, you may need to provide evidence of your English language ability. If you do not yet meet our requirements, our English Language Teaching Unit (ELTU) offers a range of courses to help you to improve your English to the necessary standard.

International Qualifications

Find your country in this list to check equivalent qualifications, scholarships and additional requirements.

Countries list

Fees and funding

Fees and funding

UK Students

This is the total course fee.

Starting in September 2023

  • £9,900

If you are resident outside the UK and the Republic of Ireland, you will need to pay a deposit of £3,000 to secure your place. This will be subtracted from your total tuition fee.

Find out more about scholarships and funding.

Did you know you can apply for a Government Postgraduate Loan? Find out if you’re eligible.

If you are a University of Leicester alumni, you may be eligible for the Centenary Alumni Discount which offers a 20% fee reduction.

International Students

This is the total course fee.

Starting in September 2023

  • £21,850

You will need to pay a deposit of £3,000 to secure your place. This will be subtracted from your total tuition fee.

From 2022 onwards, EU nationals will pay the International fee. If you are an EU national with settled or pre-settled status under the EU settlement scheme, you may qualify for the UK fee (subject to criteria).

Find out more about scholarships and funding.

If you are a University of Leicester alumni, you may be eligible for the Centenary Alumni Discount which offers a 20% fee reduction.

Careers and employability

Careers and employability

Your career development is a priority and by studying MSc Cancer Molecular Pathology and Therapeutics, you will be prepared for a dynamic career in medical research. 

Our graduates go on to a range of careers within the field including Molecular Diagnostics Consultant, Medical Researcher and roles at specialist institutes such as the Oxford Biomedical Research Centre.

The MSc Cancer Molecular Pathology and Therapeutics can also prepare you for further academic study and research, as University of Leicester qualifications are welcomed by institutions across the globe. Many of our graduates become funded PhD, DTP and DPhil students and go on to become university Lecturers themselves.

International students who study at the University of Leicester may be eligible for a Graduate Visa which grants permission to stay in the UK for at least 2 years after successful completion of their course.

Our Career Development Service is here to support you, with advice on interviews, CVs, work experience, volunteering and more. From Freshers’ Week to Graduation and beyond, they are here to help you reach your professional goals.

Related courses

Related courses



Course structure

Modules

Modules

In the taught modules you will gain expertise and knowledge in cancer molecular and cell biology, treatment, prevention, anti-cancer target discovery and validation, clinical trials, imaging, cancer risk and epidemiology and biostatistics.

Modules shown represent choices available to current students. The range of modules available and the content of any individual module may change in future years.

Project

Project

One of the most valued features of this course is the MSc Research Project, in which you will put your newly acquired practical skills and knowledge to the test. For up to six months, you will work as a member of a dedicated research team, designing and conducting your own research, culminating in the production of a dissertation.

Recent research project titles offered include:

  • Use of human adult stem cell models for assessing the efficacy of cancer chemopreventive and chemotherapeutic agents
  • Accelerating cancer prevention therapies to the clinic – towards an improved understanding of the mechanisms of action of resveratrol, curcumin and aspirin.
  • Addressing the role of amino acids metabolism in cancer metastasis
  • Monitoring the circulating cancer genome for patient follow up
  • Molecular characterisation of sputum from lung cancer patients: search for biomarkers of early detection
  • Developing a cellular model of malignant mesothelioma for translational studies
  • Development and application of PCR assays for detection of cancer driver mutations
  • Studies of epithelial mesenchymal transition as a key mechanism of tumour progression
  • Finding the genetic determinants of response to radiotherapy
  • Comet assay measures of DNA damage in cancer

Publications

Many of these projects have led to publication in highly respected scientific journals:

  • Wood JP, Smith AOJ, Bowman KJ, Thomas AL, Jones GDD (2015). ‘Comet assay measures of DNA damage as biomarkers of irinotecan response in colorectal cancer in vitro and in vivo.' Cancer Medicine 2015, 4(9):1309–1321. doi: 10.1002/cam4.477
  • Higgins JA, Zainol M, Brown K, Jones GDD (2014) ‘Anthocyans as tertiary chemopreventive agents in bladder cancer: anti-oxidant mechanisms and interaction with mitomycin C’. Mutagenesis, 29: 227-235. doi.org/10.1093/mutage/geu009
  • Britton RG, Horner-Glister E, Pomenya OA, Smith EC, Denton R, Jenkins PR, Steward WP, Brown K, Gescher A, Sale S (2012). 'Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.' Eur. J. Med. Chem. 54: 952-958 doi:10.1016/j.ejmech.2012.06.031
  • Al-Salmani K, Abbas HHK, Schulpen S, Karbaschi M, Abdalla I, Bowman KJ, So KK, Evans MD, Jones GDD, Godschalk RW, Cooke MS (2011). 'Simplified method for the collection, storage, and comet assay analysis of DNA damage in whole blood.' Free Radical Biol. Med. 51: 719-725. doi:10.1016/j.freeradbiomed.2011.05.020
  • Sayan AE, Griffiths TR, Pal R, Browne GJ, Ruddick A, Yagci T, Edwards R, Mayer NJ, Qazi H, Goyal S, Fernandez S, Straatman K, Jones GD, Bowman KJ, Colquhoun A, Mellon JK, Kriajevska M, Tulchinsky E. (2009). 'SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.' Proc. Natl. Acad. Sci. USA 106: 14884-14889 doi:10.1073/pnas.0902042106

Modules shown represent choices available to current students. The range of modules available and the content of any individual module may change in future years.

Why Leicester?

Leicester was recently ranked 2nd in the UK for its world-leading research in clinical Medicine (2021 Research Excellent Framework - REF).

The University of Leicester is home to the prestigious Leicester Cancer Research Centre that conducts pioneering research

Learn from the UK's top medical research scientists conducting real life-saving research and trials at the Leicester Precision Medicine Institute (LPMI).

Launched in 2014, this course is run and delivered by the same team that has trained more than 300 graduates over 20 years on previous Masters Degrees in this field.

Teaching and learning

The taught phase of MSc Cancer Molecular Pathology and Therapeutics consists of lectures, tutorials, demonstrations and intensive laboratory classes each lasting either four-to-six days. Successful completion of the taught phase is required to proceed to the project stage.

You will be trained in lab techniques and will develop your proficiency in experimental design. These skills will then be put into practice in the five to six month lab-based research project, which comprises two-thirds of the credits for your course.

The core lecture programme, which is shared between our various postgraduate lab-based courses, will develop your specialist knowledge. There are also optional lectures in fields related to your own, which will allow you to increase your understanding of the interdisciplinary aspects of your speciality. On days when there are no lectures, structured lab classes are run in the first semester, alongside tutorials and seminars, plus training and employability sessions.

Assessment is a mix of formal exams (MCQ, short-answer and long-answer/essay) and coursework including practical reports, presentations and other written tasks. Assessment of the five to six month laboratory research project is based on your lab performance, the written dissertation and a project presentation.

Key dates

  • Application deadline: 8 September 2023 (Please note if you require a visa to study you will be required to submit your application by 21 July 2023)
  • Deposit payment deadline: 7 August 2023
  • CAS request deadline: 1 September 2023
  • 50% payment deadline: 1 September 2023

Apply now

Course Qualification Duration Start Dates Availability
Course Cancer Molecular Pathology and Therapeutics Qualification MSc Duration 1 year full-time Start Dates September each year Availability Apply Now
Back to top
MENU